Gene changes in gastric cancer treatment monitoring
Part of Cancer, Digestive system clinical trials.
This trial looks at how gene changes called methylation can help doctors track how well treatment is working for gastric cancer. If you are newly diagnosed and have not had surgery or chemotherapy yet, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with gastric or gastroesophageal junction cancer
- You have not had any other type of cancer before
- Your cancer has not spread to distant organs like the liver or lungs
- You have not had surgery, chemotherapy, or immunotherapy for this cancer yet
- You are able to provide your medical records and tumor marker lab results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to look for early signs of stomach cancer risk using a stool sample. It checks for DNA changes and genes linked to H. pylori infection, which is a common cause of stomach cancer. It may help people who are at higher risk find problems earlier.
This trial uses a blood test to track changes in cancer-related DNA markers (methylation) to see how well treatment is working. It is for people with colorectal or small intestinal cancer that has not spread and who have not yet started treatment.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
This study monitors people after surgery for gastric cancer. It checks how patients recover and helps doctors learn more about the condition. You can join if you have stomach discomfort and are receiving care at the gastric surgery clinic of this center.
Hear when a new Gastric (Stomach) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.